Evogene Schedules First Quarter 2025 Financial Results Release

Rhea-AI Summary

Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a computational biology company focused on life-science product discovery and development, has announced it will release its Q1 2025 financial results on Wednesday, May 21, 2025. The company will host a conference call to discuss the results at 9:00 AM ET (4:00 PM Israel time) on the same day. Interested participants can register for the conference call through the company's provided link. The conference recording will be made available on Evogene's website in the following days.

News Market Reaction – EVGN

-0.88%

1 alert

-0.88% News Effect

On the day this news was published, EVGN declined 0.88%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Zoom conference call scheduled for May 21, 2025, 9:00 AM ET

REHOVOT, Israel, May 8, 2025 /PRNewswire/ -- May 8, 2025 - Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2025, on Wednesday, May 21, 2025.

Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).

To join the conference, please register in advance:

https://www.veidan-conferenceing.com/evogene

The entire conference will be available online on the company's website a few days after.

About Evogene:

Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.

Evogene established three unique tech-engines - MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).

Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries including:

1. Biomica Ltd. (www.biomicamed.com) - developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI;
2. Lavie Bio Ltd. (www.lavie-bio.com) - developing and commercially advancing, microbiome-based ag-biologicals powered by MicroBoost AI;
3. AgPlenus Ltd. (www.agplenus.com) - developing next-generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI;
4. Casterra Ag Ltd. (www.casterra.co) - developing and marketing superior castor seed varieties producing high yield and high-grade oil content on an industrial scale for the biofuel and other industries powered by GeneRator AI.

For more information, please visit: www.evogene.com.

Contact

ir@evogene.com

Tel: +972-8-9311901

Logo - https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/evogene-schedules-first-quarter-2025-financial-results-release-302449812.html

SOURCE Evogene

FAQ

When will Evogene (EVGN) release its Q1 2025 earnings?

Evogene will release its Q1 2025 financial results on Wednesday, May 21, 2025.

What time is Evogene's Q1 2025 earnings call?

Evogene's Q1 2025 earnings conference call is scheduled for 9:00 AM Eastern Time (4:00 PM Israel time) on May 21, 2025.

How can I join Evogene's Q1 2025 earnings call?

You can join by registering in advance through the company's provided link: https://www.veidan-conferenceing.com/evogene

Will Evogene's Q1 2025 earnings call be available for replay?

Yes, the entire conference will be available for replay on Evogene's website a few days after the live call.